Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines

Leukemia

Volumn 13, Issue 5, 1999, Pages 729-734

  Sekine, K ^a   Fujii, H ^a   Abe, F ^a  

^a NIPPON KAYAKU CO LTD   (Japan)

Author keywords

Apoptosis; Bestatin; Human leukemic cell lines

Indexed keywords

ANTILEUKEMIC AGENT; BESTATIN; CASPASE 3; DNA FRAGMENT; ENZYME INHIBITOR; MICROSOMAL AMINOPEPTIDASE;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033046028     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401388     Document Type: Article

References (31)

1. Umezawa H, Aoyagi T, Suda H, Hamada M, Takeuchi T. Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes. J Antibiot 1976; 29: 97-99.
2. Talmadge JE, Lenz BF, Pennington R, Long C, Phillips H, Schneider M, Tribble H. Immunomodulatory and therapeutic properties of bestatin in mice. Cancer Res 1986; 46: 4505-4510.
3. Talmadge JE, Pelus LM, Black PL, Abe F. Hematopoietic and therapeutic properties of bestatin in normal and myelosuppressed mice. Biomed Pharmacother 1991; 45: 61-69.
4. Schorlemmer HU, Bosslet K, Sedlacek HH. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes. Cancer Res 1983; 43: 4148-4153.
5. Talmadge JE, Ino K, Bierman PJ. Bestatin for anti-cancer treatments. In: Kimball ES (ed). Immuno Pharmaceuticals. CRC Press: Boca Raton, 1996, pp 135-166.
6. Abe F, Fujii A, Yoshimura K, Yugeta E, Ishizuka M, Takeuchi T. Immunomodulatory and therapeutic characteristics of bestatin (ubenimex). Int J Immunother 1990; 4: 203-209.
7. Mathé G. Bestatin, an aminopeptidase inhibitor with a multi-pharmacological function. Biomed Pharmacother 1991; 45: 49-54.
8. Leyhausen G, Schuster DK, Vaith P, Zahn RK, Umezawa H, Falke D, Müller WE. Identification and properties of the cell membrane bound leucine aminopeptidase interacting with the potential immunostimulant and chemotherapeutic agent bestatin. Biochem Pharmacol 1983; 15: 1051-1057.
9. Müller WE, Schuster DK, Zahn RK, Maidhof A, Leyhausen G, Falke D, Koren R, Umezawa H. Properties and specificity of binding sites for the immunomodulator bestatin on the surface of mammalian cells. Int J Immunopharmacol 1982; 4: 393-400.
10. Look AT, Ashmun RA, Shapiro LH, Peiper SC. Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical to aminopeptidase N. J Clin Invest 1989; 83: 1299-1307.
11. Griffin JD, Ritz J, Nadler LM, Schlossman SF. Expression of myeloid differentiation antigens on normal and malignant myeloid cells. J Clin Invest 1981; 68: 932-941.
12. Griffin JD, Ritz J, Beveridge RP, Lipton JM, Daley JF, Schlossman SF. Expression of MY7 antigen on myeloid precursor cells. Int J Cell Clon 1983; 1: 33-48.
13. Ota K, Kurita S, Yamada K, Masaoka T, Uzuka Y, Ogawa N. Immunotherapy with bestatin for acute nonlymphocytic leukemia in adults. Cancer Immunol Immunother 1986; 23: 5-10.
14. Urabe A, Mutoh Y, Mizoguchi H, Takaku F, Ogawa N. Ubenimex in the treatment of acute nonlymphocytic leukemia in adults. Ann Hematol 1993; 67: 63-66.
15. Ino K, Bierman PJ, Varney ML, Heimann DG, Kuszynski CA, Walker SA, Talmadge JE. Monocyte activation by an oral immunomodulator (bestatin) in lymphoma patients following autologous bone marrow transplantation. Cancer Immunol Immunother 1996; 43: 206-212.
16. Ezawa K, Minato K, Dobashi K. Induction of apoptosis by ubenimex (Bestatin) in human non-small-cell lung cancer cell lines. Biomed Pharmacother 1996; 50: 283-289.
17. Mashima T, Naito M, Kataoka S, Kawai H, Tsuruo T. Aspartate-based inhibitor of interleukin-1β-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia U937 cells. Biochem Biophys Res Commun 1995; 209: 907-915.
18. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau, Griffin PRY, Labelle M, Lazebnik YA et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37-43.
19. Enari M, Hug H, Nagata S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 1995; 375: 78-81.
20. Burton K. A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid. Biochem J 1956; 62: 315-323.
21. Koyama M, Hashimoto M, Asakawa N, Ishibashi M, Miyazaki H. Simultaneous determination of bestatin and p-hydroxybestatin, a major metabolite, in human serum by gas chromatography mass spectrometry. Utilization of quantitative selected ion monitoring and deuterium labelled internal standard. Biomed Mass Spectrom 1980; 7: 372-376.
22. Tieku S, Hooper NM. Inhibition of aminopeptidases N, A and W. A re-evaluation of the actions of bestatin and inhibitors of angiotensin converting enzyme. Biochem Pharmacol 1992; 44: 1725-1730.
23. Garcia-Lopez MT, Gonzalez-Muniz R, Hartoa JR, Gomez-Monterrey I, Perez C, De Ceballos ML, Lopez E, Del Rio J. Synthesis and inhibitory activities against aminopeptidase B and enkephalin-degrading enzymes of ketomethylene dipeptide analogues of arphamenines. Arch Pharm 1992; 325: 3-8.
24. Saiki I, Fujii H, Yoneda J, Abe F, Nakajima M, Tsuruo T, Azuma I. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer 1993; 54: 137-143.
25. Kanayama N, Kajiwara Y, Goto J, el Maradny E, Maehara K, Andou K, Terao T. Inactivation of interleukin-8 by aminopeptidase N (CD13). J Leuk Biol 1995; 57: 129-134.
26. Murata M, Kubota Y, Tanaka T, Iida-Tanaka K, Takahara J, Irino S. Effect of ubenimex on the proliferation and differentiation of U937 human histiocytic lymphoma cells. Leukemia 1994; 8: 2188-2193.
27. Enari M, Talanian RV, Wong WW, Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 1996; 380: 723-726.
28. Kuida K, Lippke JA, Ku G, Harding MW, Livingston DJ, Su MS, Flavell RA. Altered cytokine export and apoptosis in mice deficient in interleukin-1β-converting enzyme. Science 1995; 267: 2000-2003.
29. Mashima T, Naito M, Fujita N, Noguchi K, Tsuruo T. Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis. Biochem Biophys Res Commun 1995; 217: 1185-1192.
30. Mashima T, Tsuruo T. Involvement of ICE/CED 3 family proteases in antitumor agent-induced apoptosis. Gan To Kagaku Ryoho 1997; 24: 211-215.
31. Constam DB, Tobler AR, Rensing-Ehl A, Kemler I, Hersh LB, Fontana A. Puromycin-sensitive aminopeptidase. Sequence analysis, expression, and functional characterization. J Biol Chem 1995; 270: 26931-26939.